Valuation: Optimax Holdings

Market Cap 285M 69.75M 61.36M 57.04M 52.36M 98.12M 6.73B 99.94M 678M 264M 3.3B 262M 256M 11.42B P/E 2026 *
18.4x
P/E 2027 * 16.3x
Enterprise Value 282M 68.99M 60.69M 56.42M 51.79M 97.05M 6.66B 98.85M 670M 262M 3.27B 259M 253M 11.3B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.73x
Free-Float
23.9%
Yield 2026 *
3.01%
Yield 2027 * 3.5%
05-25 Maybank Research Downgrades Optimax Holdings to Hold from Buy; Price Target is MYR0.58 MT
05-22 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-03 Optimax to Start Offering ENT Services Following Malaysian Health Ministry's Nod MT
03-02 Optimax Holdings Berhad Receives Approval from Ministry of Health to Offer Otorhinolaryngology (Ear, Nose and Throat) Services CI
02-27 Optimax Holdings Berhad Announces Second Interim Single-Tier Dividend on Ordinary Share, Payable 30 March 2026 CI
02-26 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
11-26 Optimax Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-26 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2025, Payable on 26 December 2025 CI
08/10/25 Hong Leong Investment Bank Starts Optimax Holdings at Buy with 0.96 Ringgit Price Target MT
26/08/25 Optimax Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
28/05/25 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
27/02/25 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
27/02/25 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2024, Payable on 28 March 2025 CI
1 month+0.96%
3 months-3.67%
6 months-13.22%
Current year-8.70%
1 week 0.52
Extreme 0.525
0.53
1 month 0.52
Extreme 0.52
0.54
Current year 0.5
Extreme 0.505
0.64
1 year 0.5
Extreme 0.5
0.72
3 years 0.46
Extreme 0.46
0.74
5 years 0.46
Extreme 0.46
0.84
10 years 0.3
Extreme 0.305
0.94
Manager TitleAgeSince
Chief Executive Officer 37 30/11/2019
Director of Finance/CFO 38 31/08/2018
Chief Operating Officer 37 31/12/2023
Director TitleAgeSince
Director/Board Member 70 08/08/2018
Director/Board Member 37 30/11/2019
Director/Board Member 44 21/01/2020
Date Insider Type Main position Quantity % Market Cap.
03/06/26 Buy

Chairman

97,000 0.0179%
29/05/26 Buy

Chairman

3,000 0.0006%
18/04/25
Sena Healthcare Services Sdn. Bhd.
BuyCompany 674,000 0.1241%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+2.94%-25.53% 69.72M
+0.80%+0.25%+83.39%+41.86% 137B
+1.51%+2.97%+11.92%+34.02% 84.78B
+2.22%+4.96%+3.79%+56.43% 28.09B
-0.02%+8.15%+32.55%+58.21% 25.15B
+1.32%0.00%-14.44%-27.43% 20.05B
+17.17%+19.64%+57.16%+203.29% 20.09B
+0.50%-0.65%+62.63%+130.60% 15.12B
-0.86%-6.71%+2.39%-7.05% 14.49B
+0.65%+2.44%-5.50%-10.95% 13.07B
Average +2.33%+3.10%+23.68%+45.34% 35.84B
Weighted average by Cap. +1.88%+2.65%+42.32%+47.29%

Financials

2026 *2027 *
Net sales 152M 37.14M 32.67M 30.37M 27.88M 52.25M 3.59B 53.22M 361M 141M 1.76B 139M 136M 6.08B 157M 38.48M 33.85M 31.47M 28.89M 54.14M 3.72B 55.14M 374M 146M 1.82B 144M 141M 6.3B
Net income 15.65M 3.83M 3.37M 3.13M 2.87M 5.38M 370M 5.48M 37.2M 14.52M 181M 14.37M 14.06M 627M 17.6M 4.3M 3.79M 3.52M 3.23M 6.06M 416M 6.17M 41.83M 16.32M 204M 16.16M 15.81M 705M
Net Debt -3.1M -758K -667K -620K -569K -1.07M -73.2M -1.09M -7.37M -2.87M -35.88M -2.85M -2.78M -124M -12.4M -3.03M -2.67M -2.48M -2.28M -4.27M -293M -4.34M -29.46M -11.5M -144M -11.38M -11.14M -497M
Logo Optimax Holdings
Optimax Holdings Berhad is a Malaysia-based investment holding company offering eye specialist services. It has approximately seven satellite clinics/centers, 13 ambulatory care centers, one specialist hospital, and 288 staff/professional doctors. Its geographical segments include North Malaysia, Central Malaysia, South Malaysia, East Malaysia, and Cambodia. Its services are categorized into Refractive Surgery, Treatment of Eye Diseases and Disorders, Consultation and Dispensary Services, Oculoplastic Surgery, Plastic Surgery, and Aesthetic Services. Refractive Surgery includes laser and implant vision correction procedures. Treatment of Eye Diseases and Disorders includes cataract surgery and other medical interventions. Consultation and Dispensary Services cover doctor consultations and medication dispensing. Oculoplastic Surgery provides functional and cosmetic treatments around the eye. Its additional services include Eye Examinations, Sales of Optical Wear, and Laboratory Tests.
Employees
-
Date Price Change Volume
24/07/26 MYR 0.5250 0.00% 210,100
23/07/26 MYR 0.5250 0.00% 21,700
22/07/26 MYR 0.5250 -0.94% 90,400
21/07/26 MYR 0.5300 +0.95% 66,500
20/07/26 MYR 0.5250 0.00% 26,200
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.5250MYR
Average target price
0.6880MYR
Spread / Average Target
+31.05%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 0222 Stock